Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy

Overview of attention for article published in Frontiers in oncology, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 9 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,634 followers.

CD19m px?proj=25199 (ChiCTR1800014761). https://t.co/BesaVuriY2 (ChiCTR1800017439). https://t.co/Ekb8PjMwz8 https://t.co/FKRIPRINoZ

19 Jul 2022

Reply Repost Favourite

New research: Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy: Murine-based CD19 CAR-T (CD19m CAR-T) therapy can lead to a relatively high CR… https://t.

21 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.